Syndax Pharmaceuticals (SNDX) PT Raised to $29 at BofA Securities

May 1, 2026 4:38 AM

BofA Securities analyst Jason Zemansky raised the price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $29.00 (from $28.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found